Giant Cell Arteritis
Disease State Hub
Featured
04/07/2021
Researchers reveal that the benefit of intravenous glucocorticoid treatment in patients with giant cell arteritis may not be significant enough to risk exposure to the drugs’ toxicity.
04/07/2021
03/25/2021
While already common practice in Europe, the use of vascular ultrasound to diagnose giant cell arteritis has been limited in the United States. New research aims to change that.
03/25/2021
11/19/2020
Test your knowledge of giant cell arteritis by taking this short quiz based on facts from the American College of Rheumatology.
11/19/2020
Interactive Features
11/19/2020
Test your knowledge of giant cell arteritis by taking this short quiz based on facts from the American College of Rheumatology.
11/19/2020
12/05/2019
Do you utilize temporal artery ultrasonography or temporal artery biopsy for the diagnosis of giant cell arteritis? Let us know by taking our poll!
12/05/2019
05/05/2011
Research shows patients with large-vessel giant cell arteritis could benefit from what kind of treatment? Take our quiz and find out!
05/05/2011
03/15/2011
Do you think frozen sectioning of temporal artery biopsy is a reliable guide to determining whether to proceed with contralateral biopsy among patients with giant cell arteritiis? Take our quick poll to...
03/15/2011
02/17/2011
Lupus nephritis is a severe manifestation of systemic lupus erythematosus that can lead to end-stage renal failure. Do you know if this condition is more common among specific patient populations? Take our...
02/17/2011
Clinical Insights
12/06/2019
Dr Kermani discusses the clinical complications and manifestations associated with large-vessel vasculitis, her own challenging experience of assessing disease activity in a patient with giant cell...
12/06/2019
06/03/2019
Rochella Ostrowski, MD, from Loyola University Medical Center, discusses different classes of vasculitis, the importance of educating patients on their disease, and more.
06/03/2019
04/18/2019
In this commentary, Vikas Majithia, MD, MPH, explains results of the PEXIVAS study and how they will impact the way rheumatologists treat patients with anti-neutrophil cytoplasm antibody-associated...
04/18/2019
